Skip to main content

Table 3 Correlations among BACS measures for schizophrenia patients and healthy controls

From: Cross-cultural adaptation and validation of the Arabic version of the BACS scale (the brief assessment of cognition in schizophrenia) among chronic schizophrenic inpatients

  VM DS VF SC TM TL Composite score
In patients with schizophrenia
TL .50*** .70*** .51*** .51*** .47*** .76***
TM .40*** .48*** .47*** .36*** .47*** .74***
SC .45*** .57*** .51*** .36*** .51*** .75***
VF .65*** .67*** .51*** .47*** .51*** .80***
DS .60*** .67*** .57*** .48*** .70*** .82***
VM .60*** .65*** .45*** .40*** .50*** .76***
In healthy controls
TL .35** .41** .37** .43** .05 .45**
TM .41** .31* .37** .38** .05 .71***
SC .61*** .61*** .61*** .38** .43** .82***
VF .58*** .56*** .61*** .37** .37** .79***
DS .48*** .56*** .61*** .31* .41** .69***
VM .48*** .58*** .61*** .41** .35** .80***
  1. Significant correlation at: *p < 0.05, **p < 0.01, ***p < 0.001.
  2. VM Verbal Memory; DS Digit sequencing; VF Verbal Fluency; SC Symbol Coding; TM Token motor task; TL Tower of London.
  3. The correlation in patients with schizophrenia was controlled for duration of illness, duration of hospitalization and chlorpromazine equivalent dose